Literature DB >> 19691446

Urokinase-receptor-mediated phenotypic changes in vascular smooth muscle cells require the involvement of membrane rafts.

Julia Kiyan1, Graham Smith, Hermann Haller, Inna Dumler.   

Abstract

The cholesterol-enriched membrane microdomains lipid rafts play a key role in cell activation by recruiting and excluding specific signalling components of cell-surface receptors upon receptor engagement. Our previous studies have demonstrated that the GPI (glycosylphosphatidylinositol)-linked uPAR [uPA (urokinase-type plasminogen activator) receptor], which can be found in lipid rafts and in non-raft fractions, can mediate the differentiation of VSMCs (vascular smooth muscle cells) towards a pathophysiological de-differentiated phenotype. However, the mechanism by which uPAR and its ligand uPA regulate VSMC phenotypic changes is not known. In the present study, we provide evidence that the molecular machinery of uPAR-mediated VSMC differentiation employs lipid rafts. We show that the disruption of rafts in VSMCs by membrane cholesterol depletion using MCD (methyl-beta-cyclodextrin) or filipin leads to the up-regulation of uPAR and cell de-differentiation. uPAR silencing by means of interfering RNA resulted in an increased expression of contractile proteins. Consequently, disruption of lipid rafts impaired the expression of these proteins and transcriptional activity of related genes. We provide evidence that this effect was mediated by uPAR. Similar effects were observed in VSMCs isolated from Cav1Z(-/-) (caveolin-1-deficient) mice. Despite the level of uPAR being significantly higher after the disruption of the rafts, uPA/uPAR-dependent cell migration was impaired. However, caveolin-1 deficiency impaired only uPAR-dependent cell proliferation, whereas cell migration was strongly up-regulated in these cells. Our results provide evidence that rafts are required in the regulation of uPAR-mediated VSMC phenotypic modulations. These findings suggest further that, in the context of uPA/uPAR-dependent processes, caveolae-associated and non-associated rafts represent different signalling membrane domains.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19691446     DOI: 10.1042/BJ20090447

Source DB:  PubMed          Journal:  Biochem J        ISSN: 0264-6021            Impact factor:   3.857


  11 in total

Review 1.  Live-cell imaging of tumor proteolysis: impact of cellular and non-cellular microenvironment.

Authors:  Jennifer M Rothberg; Mansoureh Sameni; Kamiar Moin; Bonnie F Sloane
Journal:  Biochim Biophys Acta       Date:  2011-08-05

Review 2.  Lipid rafts: integrated platforms for vascular organization offering therapeutic opportunities.

Authors:  Anna Laurenzana; Gabriella Fibbi; Anastasia Chillà; Giancarlo Margheri; Tommaso Del Rosso; Elisabetta Rovida; Mario Del Rosso; Francesca Margheri
Journal:  Cell Mol Life Sci       Date:  2015-01-01       Impact factor: 9.261

3.  MicroRNA 449a can Attenuate Protective Effect of Urokinase Against Pulmonary Embolism.

Authors:  Ran Zhu; Wei-Yi Qi; Ting-Wei Liu; Fan Liu
Journal:  Front Pharmacol       Date:  2022-04-28       Impact factor: 5.988

4.  Tumor-associated soluble uPAR-directed endothelial cell motility and tumor angiogenesis.

Authors:  J S Rao; M Gujrati; C Chetty
Journal:  Oncogenesis       Date:  2013-06-24       Impact factor: 7.485

5.  Differential uPAR recruitment in caveolar-lipid rafts by GM1 and GM3 gangliosides regulates endothelial progenitor cells angiogenesis.

Authors:  Francesca Margheri; Laura Papucci; Nicola Schiavone; Riccardo D'Agostino; Silvana Trigari; Simona Serratì; Anna Laurenzana; Alessio Biagioni; Cristina Luciani; Anastasia Chillà; Elena Andreucci; Tommaso Del Rosso; Giancarlo Margheri; Mario Del Rosso; Gabriella Fibbi
Journal:  J Cell Mol Med       Date:  2014-10-14       Impact factor: 5.310

6.  Downregulation of Cavin-1 Expression via Increasing Caveolin-1 Degradation Prompts the Proliferation and Migration of Vascular Smooth Muscle Cells in Balloon Injury-Induced Neointimal Hyperplasia.

Authors:  Li-Jun Zhou; Xue-Ying Chen; Shui-Ping Liu; Lin-Lin Zhang; Ya-Nan Xu; Pan-Wei Mu; Deng-Feng Geng; Zhi Tan
Journal:  J Am Heart Assoc       Date:  2017-07-27       Impact factor: 5.501

7.  Mechanisms of action of sacubitril/valsartan on cardiac remodeling: a systems biology approach.

Authors:  Oriol Iborra-Egea; Carolina Gálvez-Montón; Santiago Roura; Isaac Perea-Gil; Cristina Prat-Vidal; Carolina Soler-Botija; Antoni Bayes-Genis
Journal:  NPJ Syst Biol Appl       Date:  2017-04-18

Review 8.  Molecular imaging of the urokinase plasminogen activator receptor: opportunities beyond cancer.

Authors:  V M Baart; R D Houvast; L F de Geus-Oei; P H A Quax; P J K Kuppen; A L Vahrmeijer; C F M Sier
Journal:  EJNMMI Res       Date:  2020-07-28       Impact factor: 3.138

Review 9.  Modulation of Cellular Function by the Urokinase Receptor Signalling: A Mechanistic View.

Authors:  Daniela Alfano; Paola Franco; Maria Patrizia Stoppelli
Journal:  Front Cell Dev Biol       Date:  2022-04-08

10.  Urokinase receptor counteracts vascular smooth muscle cell functional changes induced by surface topography.

Authors:  Yulia Kiyan; Kestutis Kurselis; Roman Kiyan; Hermann Haller; Boris N Chichkov; Inna Dumler
Journal:  Theranostics       Date:  2013-07-03       Impact factor: 11.556

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.